NL-OMON26418
Completed
N/A
Validation study to explore potential outcome parameters for a study with anti-IL-13 in allergic syndrome/asthma.
C. CusumanoCentocor Inc200 Great Valley Parkway19355-1307 MalvernPennsylvania USATel: 00 1 610 24084750 sites20 target enrollmentTBD
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- C. CusumanoCentocor Inc200 Great Valley Parkway19355-1307 MalvernPennsylvania USATel: 00 1 610 2408475
- Enrollment
- 20
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
/A
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Male or female subjects;
- •2\. 18\-50 years of age with atopic rhinitis.
Exclusion Criteria
- •1\. Current smokers (\<6 months stopped) or ex\-smokers (\>10 packyears);
- •2\. Any clinically significant deviation from normal in either the general physical examination or laboratory parameters as evaluated by the investigator at Occasion 1;
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
N/A
Proeftuin Integrative MedicinePatients with chronic musculoskeletal pain, (Osteo)arthritis, rheumatoid arthritis, fibromyalgia, low back pain, neck pain, tennis elbow or golfers arm, non-specific joint complaints, reuma, artrose, fibromyalgie, klachten bewegingsapparaatNL-OMON27322268
Completed
N/A
Exploratory study to investigate the effects of a new infant formula in healthy term infants during the first 6 months of life.healthy infantsNL-OMON20946Danone Research - Centre for Specialised Nutrition350
Completed
N/A
A clinical feasibility study to evaluate the effectiviness and safety of VivescOs TM as bone graft for reconstruction of intra-oral osseous defects.NL-OMON24005Isotis, Bilthoven, the Netherlands10
Unknown
N/A
Applying Short-term Interactive Video Games on Community Patients With Mental DisordersPsychiatryNursingNCT04346303National Taiwan University Hospital60
Completed
Phase 4
Triggering of Final Oocyte Maturation With GnRHa (Buserelin) in GnRH Antagonist CyclesOHSS (Ovarian Hyperstimulation)NCT00627406Regionshospitalet Viborg, Skive384